Related Experiment Videos

Arterial occlusions in neonates: use of fibrinolytic therapy

J L Strife1, W S Ball, R Towbin

  • 1Division of Radiology, Children's Hospital Medical Center, Cincinnati, OH 45229-2899.

Radiology
|February 1, 1988
PubMed

Insights

Fibrinolytic therapy effectively treated symptomatic thrombosis in neonates, particularly central thrombosis after umbilical artery catheterization. Prompt diagnosis and treatment are crucial for positive outcomes in these critical cases.

Area of Science:

  • Neonatal Medicine
  • Pediatric Cardiology
  • Vascular Surgery

Background:

  • Umbilical artery catheterization is associated with neonatal thrombosis.
  • Prompt recognition and management of neonatal extremity ischemia or aortic thrombosis are critical.

Purpose of the Study:

  • To review diagnostic methods and treatment responses to fibrinolytic agents in neonates with symptomatic thrombosis.
  • To evaluate the efficacy of fibrinolytic therapy for peripheral and central thrombosis in infants.

Main Methods:

  • Retrospective review of eight infants with symptomatic thrombosis treated with fibrinolytic agents.
  • Diagnostic tools included real-time sonography and umbilical arteriography.
  • Analysis of treatment response and patient outcomes.

Main Results:

  • Fibrinolytic therapy achieved complete lysis in one of two infants with peripheral thrombosis.
  • Five of six infants with central thrombosis experienced complete clot lysis.
  • One premature infant developed intracranial hemorrhage and died.

Conclusions:

  • Fibrinolytic therapy is a viable treatment option for neonatal thrombosis, especially central thrombosis.
  • Early diagnosis via sonography and arteriography aids management.
  • Careful patient selection and monitoring are essential due to potential complications.

Related Concept Videos